相关实验视频
Updated: Jun 27, 2025

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
167
在人工智能时代治疗败血症的葡萄糖皮质体治疗:对当前和未来方法的调查
Chenglong Liang1,2,3, Shuo Pan2, Wei Wu4
1The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Computational and structural biotechnology journal
|April 29, 2024
概括
皮质类固醇可能有助于治疗败血症,但其使用是有争议的. 将皮质类固醇治疗与人工智能 (AI) 结合起来,可以个性化治疗并改善败血症患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 败血症是一种危及生命的疾病,其特点是由于宿主对感染的反应失调而导致器官衰竭.
- 败血症中的超炎性表型表明炎症调节,皮质类固醇是关键的治疗方式.
- 在败血症中最佳使用皮质类固醇仍然存在争议,需要进一步了解它们的影响.
研究的目的:
- 审查对治疗败血症的皮质类固醇治疗的随机对照试验 (RCT).
- 分析不断发展的治疗败血症的临床指导方针.
- 探索人工智能 (AI) 在增强败血症皮质类固醇治疗中的作用.
主要方法:
- 在败血症中对皮质类固醇进行RCT的综合文献综述.
- 对当前临床实践指南的分析.
- 探索AI在败血症诊断,预后和治疗中的应用.
主要成果:
- 皮质类固醇治疗是一种公认的,但有争议的败血症治疗方法.
- 人工智能提供先进的数据处理,以改善败血症管理的潜力.
- 人工智能可以确定优化在败血症中使用皮质类固醇的新策略.
结论:
- 将人工智能与皮质类固醇治疗结合起来,可能会导致个性化和有效的败血症治疗.
- 人工智能驱动的洞察力可以解决治疗败血症的皮质类固醇应用方面的知识差距.
- 这种综合方法显示出改善毒症管理临床结果的前景.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
239
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
239
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Acute Respiratory Failure-V
136
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136
Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323

